paclitaxel has been researched along with Atypical Endometrial Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Che, YC; Li, X; Pan, XY; Zhang, Y | 1 |
| Wang, HJ; Zheng, WX | 1 |
1 review(s) available for paclitaxel and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
[Precursor lesions of type II endometrial cancer: diagnostic criteria and pathogenesis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma in Situ; Cystadenocarcinoma, Papillary; Cystadenocarcinoma, Serous; Disease Progression; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Humans; Hysterectomy; Paclitaxel; Precancerous Conditions; Radiotherapy, Adjuvant; Uterine Neoplasms | 2007 |
1 other study(ies) available for paclitaxel and Atypical Endometrial Hyperplasia
| Article | Year |
|---|---|
[Study of claudin-4 in the diagnosis and treatment of endometrial carcinoma].
Topics: Animals; Cell Line, Tumor; Cisplatin; Claudin-4; Disease Models, Animal; Endometrial Hyperplasia; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Paclitaxel; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transplantation, Heterologous | 2013 |